Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_assertion type Assertion NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_head.
- NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_assertion description "[Based on the recent identification of TET2 mutations, we evaluated the mutational status of TET1, TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_provenance.
- NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_assertion evidence source_evidence_literature NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_provenance.
- NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_assertion SIO_000772 19420352 NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_provenance.
- NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_assertion wasDerivedFrom befree-20150227 NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_provenance.
- NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_assertion wasGeneratedBy ECO_0000203 NP948719.RANdVBs1HhF-sfPXWkFcqk7QBP4laAvNUBODAiLbB41uM130_provenance.